Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...
Hosted on MSN51m
Your Morning: Trump’s plan to slash USAID staffThe Trump administration presented its plan to cut staffing for U.S. aid projects around the world as part of its dismantling of the USAID.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback